` QNTM (Quantum BioPharma Ltd) vs S&P 500 Comparison - Alpha Spread

Q
QNTM
vs
S&P 500

Over the past 12 months, QNTM has significantly outperformed S&P 500, delivering a return of +161% compared to the S&P 500's +13% growth.

Stocks Performance
QNTM vs S&P 500

Loading
QNTM
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
QNTM vs S&P 500

Loading
QNTM
S&P 500
Difference
www.alphaspread.com

Performance By Year
QNTM vs S&P 500

Loading
QNTM
S&P 500
Add Stock

Competitors Performance
Quantum BioPharma Ltd vs Peers

S&P 500
QNTM
LLY
JNJ
NOVO B
ROG
Add Stock

Quantum BioPharma Ltd
Glance View

Market Cap
53.8m USD
Industry
Pharmaceuticals

Quantum BioPharma Ltd is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

QNTM Intrinsic Value
Not Available
Q
Back to Top